Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of caution.

Ong, Fenny; Wang, Jingzhao; Van der Elst, Wim; Verbeke, Geert; Molenberghs, Geert; Alonso, Ariel

Ong, Fenny; Wang, Jingzhao; Van der Elst, Wim; Verbeke, Geert; Molenberghs, Geert; Alonso, Ariel.

Afiliação

Ong F; I-Biostat, Universiteit Hasselt, Diepenbeek, Belgium.
Wang J; Center for Drug Evaluation, NMPA, People's Republic of China.
Van der Elst W; The Janssen Pharmaceutical, companies of Johnson & Johnson, Beerse, B-2340, Belgium.
Verbeke G; I-Biostat, Universiteit Hasselt, Diepenbeek, Belgium.
Molenberghs G; I-BioStat, KU Leuven, Leuven, Belgium.
Alonso A; I-Biostat, Universiteit Hasselt, Diepenbeek, Belgium.

J Biopharm Stat ; 32(5): 705-716, 2022 Sep 03.

Article em En | MEDLINE | ID: mdl-34958630

Assuntos

Algoritmos; Modelos Estatísticos; Biomarcadores; Humanos

Palavras-chave

Surrogate markers; lme; lmer; meta-analytic approach; proc mixed

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Algoritmos / Modelos Estatísticos Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Biopharm Stat Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google